Announcements Trials
Browse Landscape

Phase

Phase NA 2

Status

Recruiting 3Not yet recruiting 2

Sponsor Class

OTHER 5

Study Type

Observational 3Interventional 2

Sponsor

Cancer Type

Tumor-Agnostic 1Thoracic 1Breast 1

Conditions

Neoplasms 1Lung Neoplasms 1Hypoactive Delirium 1Cancer Diagnosis 1Breast Neoplasms 1

Interventions

Cyclophosphamide 2067Radiotherapy 1990Cisplatin 1856Carboplatin 1560Gemcitabine 1454Paclitaxel 1320Bevacizumab 1320pembrolizumab 1238Docetaxel 1227Oxaliplatin 1184Capecitabine 1178Fluorouracil 1083Dexamethasone 979Magnetic Resonance Spectroscopy 971Nivolumab 936Rituximab 929Drug Therapy 915Surveys and Questionnaires 899Doxorubicin 845Etoposide 843Radiosurgery 816Blood Specimen Collection 816Irinotecan 784Cytarabine 743fludarabine 726Leucovorin 684Surgical Procedures, Operative 640Lenalidomide 618Biopsy 594fludarabine phosphate 569

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

5 trials
RecentStart dateEnrollment
OTHER × Health Personnel × Clear all
NCT05837039 2026-03-04

A Comparison of Healthcare Provider and Caregiver Perception of Discomfort in Advanced Cancer Patients Who Have a Hypoactive Delirium

M.D. Anderson Cancer Center

Recruiting
100 enrolled

Hypoactive Delirium

NCT07416513 2026-02-18

ALTHEA

European Institute of Oncology

Phase NA Recruiting
200 enrolled

Cancer Diagnosis

NCT06762496 2025-11-28

A New Tool to Promote Patient's Engagement in Their Healthcare Process

European Institute of Oncology

Recruiting
180 enrolled
Breast

Breast Neoplasms

NCT06965608 2025-05-11

FLACC-Brazil

Hospital Israelita Albert Einstein

Phase NA Not yet recruiting
1,200 enrolled
Tumor-Agnostic

Neoplasms

NCT06592430 2024-09-19

The Impact of Communication With Healthcare Providers Via WeChat on Survival Outcomes for Lung Cancer Patietns

Shanghai Pulmonary Hospital, Shanghai, China

Not yet recruiting
2,000 enrolled
Thoracic

Lung Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡